EPA治疗后对糖尿病性视网膜病变大鼠视网膜组织VEGF、flk1、bax、bcl2表达的影响

doi:10.3969/j.issn.10073205.2018.03.016

摘要/Abstract

摘要： ［摘要］〓
〖HTH〗目的〖HTSS〗〖KG*2〗观察二十碳五烯酸（eicosapentaenoic acid，EPA）治疗后对糖尿病性视网膜病变（diabetic retinopathy，DR）大鼠视网膜组织血管内皮生长因子（vascular endothelial growth factor，VEGF）、flk1、bax、bcl2表达的影响，以阐明EPA治疗DR的机制。
〖HTH〗方法〖HTSS〗〖KG*2〗链脲佐菌素(streptozocin，STZ)60 mg/kg腹腔注射制备SD大鼠糖尿病模型共36只，随机分为4组： C组12只成模后1个月 VEGF(0.05 μg)双眼玻璃体注射；D组12只成模后1个月VEGF（0.05 μg）+EPA（0.5 μg）双眼玻璃体注射； E组8只成模后 1个月 VEGF（0.05 μg）双眼玻璃体注射，2周后 EPA（0.5 μg）双眼玻璃体注射； F组4只成模后1个月VEGF（0.05 μg）双眼玻璃体注射，4周后 EPA（0.5 μg）双眼玻璃体注射。采用完全随机设计实验方法和免疫组织化学方法对联合注药法建立的大鼠增殖型糖尿病性视网膜病变（proliferative diabetic rentinopathy，PDR）模型及EPA治疗后视网膜组织中VEGF、flk1、bax、bcl2的表达进行观察，应用MIAS 1998型图像分析系统测定其在视网膜节细胞层和内网层的平均光密度值。
〖HTH〗结果〖HTSS〗〖KG*2〗背景期和增殖前期给药组VEGF、flk1在视网膜内层的表达减弱，而增殖期给药对抑制VEGF表达无效。 EPA可通过减弱bax在视网膜的表达抑制DR进展，背景期和增殖前期疗效优于增殖期。 EPA可抑制DR进展，使bcl2在视网膜的代偿性高表达减弱，8周时减弱消失，bcl2继续发挥保护神经细胞作用。
〖HTH〗结论〖HTSS〗〖KG*2〗EPA在背景期和增殖前期体内应用可通过封闭flk1受体、抑制VEGF发挥作用延缓DR进展；还可下调凋亡促进基因bax的表达抑制视网膜神经细胞的凋亡减轻DR进展；早期可抑制机体的保护性bcl2高表达，但在8周时消失，bax/bcl2比值降低，对周细胞的缺失有保护作用。

关键词: 糖尿病视网膜病变, 血管内皮生长因子类, 二十碳五烯酸

Abstract: ［Abstract］ Objective〖HTSS〗〓To identify the effect of eicosapentaenoic acid (EPA) on expression of vascular endothelial growth factor(VEGF)、 flk1、bax、bcl2 in retinas of diabetic rats and to elucidate the mechanism of EPA on diabetic retinopathy(DR) treatment.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓Thirtysix diabetic models of SD rats were prepared by intraperitoneal injection of streptozotocin(STZ) 60 mg/kg. One month later the rats were divided into 4 groups randomly. C：12 rats were received intravitreal injection of VEGF(0.05 μg) both eyes. D：12 rats were received intravitreal injection of VEGF(0.05 μg) and EPA（0.5 μg） both eyes. E：8 rats were received intravitreal injection of VEGF(0.05 μg) both eyes，and 2 weeks later received intravitreal injection of EPA（0.5 μg） both eyes. F：4 rats were received intravitreal injection of VEGF(0.05 μg) both eyes，and 4 weeks later received intravitreal injection of EPA（0.5 μg） both eyes. Using complete random design empirical method，we observed the variation of VEGF、flk1、bax、bcl2 expression in diabetic rat retina established by symphysial injection and those treated by EPA by immunohistochemistry and measured the average optical density value of them in retinal ganglion cell layer and inner plexiform layer by MIAS 1998 type image analysis system.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓VEGF 、flk1 expression was weakened in inner retina layer after EPA injection during background stage and preproliferation stage. But it is ineffective as given EPA during proliferation stage. EPA can weaken expression of bax in retinas and then inhibit advancement of DR after injection intravitreously. Therapeutic efficacy was better as given during background and preproliferation stage than during proliferation stage. EPA can weaken the higher expression of bcl2 in retinas by inhibiting advancement of DR, as time went to 8 weeks, the weakening effect disappeared and bcl2 continued to protect the nerve cells.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓EPA can inhibit advancement of DR not only by suppressing VEGF effect through blocking flk1 receptor as given during background and preproliferation stages in vivo, but also by inhibiting apoptosis of retinal nerve cells through downregulating apoptosis trigger gene bax expression. At early stage, it can lessen compensatory higher bcl2 expression. At 8 weeks, this effect disappeared and bax/bcl2 ratio was decreased，which had the protection to pericyte deficiency.

Key words: diabetic retinopathy, vascular endothelial growth factor, eicosapentaenoic acid

董白霞1，王家瑶2，包永琴1，王振东1. EPA治疗后对糖尿病性视网膜病变大鼠视网膜组织VEGF、flk1、bax、bcl2表达的影响[J]. 河北医科大学学报, doi: 10.3969/j.issn.10073205.2018.03.016.

DONG Baixia1， WANG Jiayao2， BAO Yongqin1， WANG Zhendong1.

Effect of EPA therapy on the expression of VEGF, Flk1, Bax and Bcl2 in retina of diabetic retinopathy rats

[J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.10073205.2018.03.016.

[1]	李雪景, 陈冬梅, 段佳良, 姚一民, 尚庆丽. 联合手术治疗增殖性糖尿病视网膜病变的继发性闭角型新生血管性青光眼的临床效果观察 [J]. 河北医科大学学报, 2023, 44(3): 319-323.
[2]	吴苏敏, 周欣, 王丽波. 血清CMKLR1、FSTL1水平与糖尿病视网膜病变严重程度相关性 [J]. 河北医科大学学报, 2023, 44(2): 189-193,213.
[3]	李爽, 张海召, 姜晓丹, 蒋燕铌. 玻璃体腔注射阿柏西普联合全视网膜光凝治疗糖尿病视网膜病变增殖期黄斑水肿的疗效分析[J]. 河北医科大学学报, 2022, 43(2): 183-186,197.
[4]	袁健生, 周念, 蔡甜, 杜燕娇, 贾岩, 蒋子裕. 血清淀粉样蛋白A、血管内皮生长因子与类风湿关节炎相关性研究[J]. 河北医科大学学报, 2022, 43(2): 213-217.
[5]	王艳新, 贾冠美, 曹朗, 曹顺义, 张士宏. 血浆miR-let-7e-5p、LncRNA NEAT1表达水平与2型糖尿病视网膜病变的关系 [J]. 河北医科大学学报, 2022, 43(10): 1167-1171.
[6]	孟桐羽, 赵涛, 宋玉霞, 赵芳, 李盼, 赵健. miR-107在卵巢癌组织中的表达及其对VEGFA的影响[J]. 河北医科大学学报, 2021, 42(7): 818-822.
[7]	白洁, 宋妮娟. 基于聚焦解决模式的强化护理对糖尿病性视网膜病变患者负性情绪、依从性及视功能的影响[J]. 河北医科大学学报, 2021, 42(11): 1298-1301,1306.
[8]	刘慧（综述）, 刘丹岩（审校）. 增殖性糖尿病视网膜病变玻璃体切除术后发生新生血管性青光眼的影响因素[J]. 河北医科大学学报, 2021, 42(11): 1357-1361.
[9]	窦方方, 李振通, 曹素平, 邓志峰. 原花青素调控miR-21表达对糖尿病视网膜病变大鼠血管内皮细胞功能及视网膜神经节细胞的保护机制研究[J]. 河北医科大学学报, 2020, 41(12): 1379-1383,1388.
[10]	陈伽俐，李〓炜，李〓林*. 雷珠单抗联合577 nm激光光凝治疗重度非增生型糖尿病视网膜病变伴黄斑水肿的效果观察[J]. 河北医科大学学报, 2019, 40(7): 834-837.
[11]	李美艳. 宫内膜癌中VM、VEGF对PLN转移的影响及预后分析[J]. 河北医科大学学报, 2018, 38(8): 938-942.
[12]	刘〓影，王红霞，周娜磊，段佳良，杨〓欣，安建斌*. 预警机制人性化护理在PDR玻璃体切除患者中的应用观察[J]. 河北医科大学学报, 2018, 38(6): 688-690,694.
[13]	王霖霞，苏〓娜，张云娜，郭宁宁，王光亚. 25羟维生素D3、hsCRP与糖尿病视网膜病变相关性研究[J]. 河北医科大学学报, 2018, 38(10): 1149-1152,1184.
[14]	赵会颖1，杨永刚1,张建平1，李贵琴1，钱玉中2，李倩倩1. 远程缺血预适应对TIA的保护作用及机制研究#br#[J]. 河北医科大学学报, 2018, 38(1): 15-18,28.
[15]	王〓芳1，尹立勇2*，娄〓娟3，顾〓涛1，付占昭1. HIF1α及其靶基因在宫颈癌中的表达#br#[J]. 河北医科大学学报, 2017, 37(7): 764-769.